Nuvation Bio Completes Acquisition of AnHeart Therapeutics

10.04.2024 - Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of the acquisition of ... Seite 1

Related Keywords

Nuvation Bio ,Junyuan Jerry Wang , ,David Hung ,Chief Executive ,Min Cui ,Managing Director ,Decheng Capital ,Chief Executive Officer ,Non Voting Convertible Preferred Stock ,Nuvation Bio Chart ,Uvation Bio Kurs ,Uvation Bio Aktie ,